Then, we further investigated the prognosis effect of PARP3 in patients with breast cancer with both proteomic and genomic data, and the results were consistent, which mean that PARP3 is still a protection factor to patients in proteomic level (p = 0.047, Figure 3D). The gene discussed is PARP3; the disease is breast carcinoma.